# Hemodialysis and Erythrocyte Fatty-Acid Status: a Lipidomics Study

> **NCT03857984** · NA · COMPLETED · sponsor: **Benjamin Gollasch** · enrollment: 30 (actual)

## Conditions studied

- Fatty Acid Metabolism
- Erythrocytes
- Lipidomics
- Hemodialysis

## Interventions

- **OTHER:** Blood sampling

## Key facts

- **NCT ID:** NCT03857984
- **Lead sponsor:** Benjamin Gollasch
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-02-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857984, "Hemodialysis and Erythrocyte Fatty-Acid Status: a Lipidomics Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03857984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*